National Diffuse Midline Glioma Awareness Day Act
An Act respecting National Diffuse Midline Glioma Awareness Day
- Introduced
- APRIL 19, 2023
Legislative timeline
- 1st—
- 2nd—
- Comm.—
- 3rd—
- SenateApr 19, 2023
- Assent—
Bill overview
Bill S-260, “National Diffuse Midline Glioma Awareness Day Act”, is a federal bill from session 44-1. Its long title is “An Act respecting National Diffuse Midline Glioma Awareness Day”.
It reached Senate consideration on April 19, 2023. Its latest recorded status is “In senate”.
This overview is written automatically from the registry and vote records on this page and updates when they sync. It describes the bill's path, not its merits.
PLAIN-LANGUAGE SUMMARY
What you need to know
No summary of this bill is available yet. The official record carries only its title; see the sources in the sidebar for the full text.
Vote roll
No division has been recorded for this bill yet.
Keep exploring
Other bills from this session
- Bill S-257An Act to amend the Canadian Human Rights Act (protecting against discrimination based on political belief)
- Bill S-258Fairness for All Canadian Taxpayers Act (measuring the tax gap to fight international tax evasion)
- Bill S-259Hellenic Heritage Month Act
- Bill S-261Can’t Buy Silence Act
- Bill S-262An Act to amend the Citizenship Act (Oath of Citizenship)
- Bill S-263National Strategy to Combat Human Trafficking Act